Search

Cancer is a Toxic health concern worldwide, it happens when cellular modifications cause the irregular growth and division of human cells. Several traditional approaches such as therapies and wet laboratory-based methods have been applied to treat cancer cells. However, these methods are considered less effective due to their high cost and diverse side effects. According to recent advancements, peptide-based therapies have attracted the attention of scientists because of their high selectivity. Peptide therapy can efficiently treat the targeted cells, without affecting the normal cells. Due to the rapid increase of peptide sequences, an accurate prediction model has become a challenging task. Keeping the significance of anticancer peptides (ACPs) in cancer treatment, an intelligent and reliable prediction model is highly indispensable. In this paper, a FastText-based word embedding strategy has been employed to represent each peptide sample via a skip-gram model. After extracting the peptide embedding descriptors, the deep neural network (DNN) model was applied to accurately discriminate the ACPs. The optimized parameters of DNN achieved an accuracy of 96.94 %, 93.41 %, and 94.02 % using training, alternate, and independent samples, respectively. It was observed that our proposed cACP-DeepGram model outperformed and reported ~10 % highest prediction accuracy than existing predictors. It is suggested that the cACP-DeepGram model will be a reliable tool for scientists and might play a valuable role in academic research and drug discovery. The source code and the datasets are publicly available at https://github.com/shahidakbarcs/cACP-DeepGram. [ABSTRACT FROM AUTHOR]

World widely, cancer is considered a fatal disease and remains the major cause of death. Conventional medication approaches using therapies and anticancer drugs are deemed ineffective due to its high cost and harmful impacts on the normal cells. However, the innovation of anticancer peptides (ACPs) provides an effective way how to deals with cancer affected cells. Due to the rapid increases in peptide sequences, truly characterization of ACPs has become a challenging task for investigators. In this paper, an effort has been carried out to develop a reliable and intelligent computational method for the accurate discrimination of anticancer peptides. Three statistical feature representation schemes namely: Quasi-sequence order (QSO), conjoint triad feature, and Geary autocorrelation descriptor are applied to express motif of the target class. In order to eradicate irrelevant and noisy features, while select salient, profound and high variated features, principal component analysis is employed. Furthermore, the diverse nature of learning algorithms is utilized in order to select the best operational engine for the proposed model. After examining the empirical outcomes, support vector machine obtained quite encouraging results in combination with QSO feature space. It has achieved an accuracy of 96.91% and 89.54% using the main dataset and alternative dataset, respectively. It is observed that our proposed model shows an outstanding improvement compared to literature methods. It is expected that the developed model may be played a useful role in research academia as well as proteomics and drug development. • Computational model is developed for prediction of anticancer peptides. • Quasi-sequence order, conjoint triad feature, and Geary autocorrelation descriptor are used as feature extraction scheme. • PCA is applied as feature selection scheme. • Various classification algorithms are utilized. • Proposed model achieved quite promising results. [ABSTRACT FROM AUTHOR]